{"id":"cetrorelix-pamoate","safety":{"commonSideEffects":[{"rate":null,"effect":"Hot flashes"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Decreased libido"},{"rate":null,"effect":"Erectile dysfunction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By antagonizing GnRH receptors in the pituitary gland, cetrorelix pamoate rapidly suppresses gonadotropin release without the initial flare effect seen with GnRH agonists. This leads to suppression of sex hormone production (testosterone and estrogen), making it useful in hormone-dependent conditions. The pamoate salt formulation provides extended-release characteristics for sustained therapeutic effect.","oneSentence":"Cetrorelix pamoate is a gonadotropin-releasing hormone (GnRH) antagonist that blocks GnRH receptors to suppress luteinizing hormone and follicle-stimulating hormone secretion.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:05:24.101Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prostate cancer (hormone-dependent)"},{"name":"Ovarian suppression in assisted reproductive technology"}]},"trialDetails":[{"nctId":"NCT06378268","phase":"NA","title":"PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-24","conditions":"Progestins Primed Ovarian Stimulation","enrollment":626},{"nctId":"NCT07340827","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)","status":"RECRUITING","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2026-02-05","conditions":"Infertility","enrollment":333},{"nctId":"NCT05326087","phase":"PHASE3","title":"Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A","status":"NOT_YET_RECRUITING","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2026-06-01","conditions":"Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Polycystic Ovarian Syndrome","enrollment":204},{"nctId":"NCT07350317","phase":"PHASE4","title":"Trial Comparing Subcutaneous Natural Progesterone (Prolutex) vs. Cetrorelix Acetate for Luteinizing Hormone Surge Suppression in Freeze-All IVF Cycles.","status":"NOT_YET_RECRUITING","sponsor":"Trust Fertility Clinic","startDate":"2026-01","conditions":"Assisted Reproductive Techniques","enrollment":230},{"nctId":"NCT02892942","phase":"PHASE4","title":"NATural Ovarian Stimulation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-01-13","conditions":"Infertility","enrollment":129},{"nctId":"NCT06023602","phase":"NA","title":"Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF","status":"RECRUITING","sponsor":"Northwest Women's and Children's Hospital, Xi'an, Shaanxi","startDate":"2024-02-27","conditions":"Infertility","enrollment":1338},{"nctId":"NCT03680053","phase":"NA","title":"Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF","status":"TERMINATED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-04-10","conditions":"Infertility, ART","enrollment":220},{"nctId":"NCT04414748","phase":"PHASE3","title":"Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-06-10","conditions":"Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Euploid Rate","enrollment":400},{"nctId":"NCT06868576","phase":"PHASE3","title":"PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2023-01-03","conditions":"PPOS, GnRH Antagonist, Assisted Reproductive Techniques","enrollment":328},{"nctId":"NCT06812559","phase":"","title":"Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2023-12-01","conditions":"Controlled Ovarian Hyperstimulation, Polycystic Ovarian Syndrome","enrollment":100},{"nctId":"NCT06572930","phase":"","title":"Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2024-12-16","conditions":"Ovarian Stimulation","enrollment":150},{"nctId":"NCT05447208","phase":"PHASE3","title":"Effect of GH on the Blastocyst Euploid Rate in AMA Patients","status":"RECRUITING","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2022-08-01","conditions":"Preimplantation Genetic Testing, Growth Hormone, Age, Parental","enrollment":400},{"nctId":"NCT06608186","phase":"PHASE1, PHASE2","title":"Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!","status":"COMPLETED","sponsor":"Ahmed Saad","startDate":"2024-10-01","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":50},{"nctId":"NCT06778733","phase":"EARLY_PHASE1","title":"Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders","status":"COMPLETED","sponsor":"University of Athens","startDate":"2022-01-01","conditions":"Female Infertility","enrollment":22},{"nctId":"NCT05767086","phase":"NA","title":"Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2023-03-15","conditions":"Infertility","enrollment":297},{"nctId":"NCT06571214","phase":"PHASE4","title":"Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment","status":"NOT_YET_RECRUITING","sponsor":"Nanjing University","startDate":"2024-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT06396390","phase":"PHASE4","title":"Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nesta Clinic","startDate":"2024-08-01","conditions":"IVF, Fertility Issues, Infertility","enrollment":152},{"nctId":"NCT02478775","phase":"NA","title":"Dysregulation of FSH in Obesity: Functional and Statistical Analysis","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2015-07","conditions":"Obesity, Fertility","enrollment":99},{"nctId":"NCT04719000","phase":"PHASE4","title":"PErsonalized Addition of Recombinant LH in Ovarian Stimulation","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-02-04","conditions":"Infertility","enrollment":120},{"nctId":"NCT03809429","phase":"PHASE3","title":"Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2019-04-29","conditions":"Infertility, Female","enrollment":437},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":"IVF","enrollment":240},{"nctId":"NCT04671966","phase":"PHASE4","title":"Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction","status":"UNKNOWN","sponsor":"The University of Texas at Arlington","startDate":"2018-09-13","conditions":"Heart Diseases, Left Ventricular Dysfunction","enrollment":100},{"nctId":"NCT06212102","phase":"PHASE2","title":"Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation","status":"NOT_YET_RECRUITING","sponsor":"Bedaya Hospital","startDate":"2024-02","conditions":"Infertility","enrollment":120},{"nctId":"NCT06191809","phase":"NA","title":"Evaluate the Effectiveness of Progestin-Primed Versus GnRH Antagonist Protocols in Vietnamese Women Undergoing In-vitro Fertilization","status":"UNKNOWN","sponsor":"Hanoi Medical University","startDate":"2023-02-14","conditions":"IVF","enrollment":200},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection","enrollment":50},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04447872","phase":"NA","title":"The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol","status":"UNKNOWN","sponsor":"Northwell Health","startDate":"2020-09-15","conditions":"Infertility, Diminished Ovarian Reserve, IVF","enrollment":142},{"nctId":"NCT04414761","phase":"PHASE3","title":"Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-06-04","conditions":"IVF, GnRH Antagonist, PPOS","enrollment":784},{"nctId":"NCT05951400","phase":"PHASE2, PHASE3","title":"Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist in With Expected High Ovarian Response Undergoing in Vitro Fertilization","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-08-20","conditions":"IVF, PCO","enrollment":200},{"nctId":"NCT05972902","phase":"PHASE3","title":"Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-15","conditions":"IVF","enrollment":387},{"nctId":"NCT05738382","phase":"PHASE2","title":"Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures","status":"UNKNOWN","sponsor":"Bio Genuine (Shanghai) Biotech Co., Ltd.","startDate":"2023-08","conditions":"Assisted Reproductive Technology, Controlled Ovarian Hyperstimulation","enrollment":240},{"nctId":"NCT05900661","phase":"PHASE2, PHASE3","title":"The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-30","conditions":"Poor Responders","enrollment":300},{"nctId":"NCT05939284","phase":"NA","title":"Progesterone-Primed Ovarian Simulation in Controlled-ovarian Simulation of Infertile PCOS Patients","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2021-06-01","conditions":"PCOS","enrollment":238},{"nctId":"NCT04931355","phase":"NA","title":"Acupuncture in the Freeze-all IVF Cycle","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2023-06-01","conditions":"Acupuncture, Female Infertility","enrollment":90},{"nctId":"NCT04616729","phase":"PHASE1, PHASE2","title":"DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":"Breast Cancer Female","enrollment":30},{"nctId":"NCT04108039","phase":"NA","title":"Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2019-09-25","conditions":"Infertility, IVF, Preimplantation Diagnosis","enrollment":44},{"nctId":"NCT04071574","phase":"PHASE1, PHASE2","title":"Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility","status":"COMPLETED","sponsor":"Lebanese University","startDate":"2018-02-01","conditions":"Female Infertility, Female Infertility Due to Ovulatory Disorder, Premature Ovarian Failure","enrollment":200},{"nctId":"NCT05847660","phase":"NA","title":"Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient","status":"UNKNOWN","sponsor":"Fayoum University","startDate":"2023-06-01","conditions":"Polycystic Ovary Syndrome, Infertility, IVF","enrollment":210},{"nctId":"NCT05778331","phase":"","title":"The Difference Between POSEIDON Group 3 and Group 4 as Regards IVF","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-10","conditions":"Infertility, Female, IVF","enrollment":340},{"nctId":"NCT05751681","phase":"NA","title":"Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2023-02-20","conditions":"Ovary Cyst, Fertility Issues","enrollment":79},{"nctId":"NCT05577806","phase":"","title":"DYG Versus Cetrorelix in Oocyte Donation","status":"COMPLETED","sponsor":"Clinica de la Mujer Medicina Reproductiva, Chile","startDate":"2017-01-01","conditions":"Infertility, Female, Fertility Disorders","enrollment":202},{"nctId":"NCT04052607","phase":"NA","title":"Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol for Freeze-all Cycles","status":"TERMINATED","sponsor":"Ibn Sina Hospital","startDate":"2019-09-10","conditions":"Infertility","enrollment":56},{"nctId":"NCT04537078","phase":"PHASE3","title":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT05112692","phase":"NA","title":"Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-11","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":200},{"nctId":"NCT04854707","phase":"","title":"An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2020-01-12","conditions":"Reproductive Issues, Reproductive Disorder, Fertility Disorders","enrollment":5484},{"nctId":"NCT04993924","phase":"PHASE4","title":"GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2021-05-01","conditions":"IVF, Ovarian Cysts","enrollment":15},{"nctId":"NCT04935073","phase":"PHASE3","title":"Traditional Chinese Medicine Herbs in the Freeze-all IVF Cycle","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-06-15","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT04842825","phase":"PHASE3","title":"Sequential Therapy of TCM Herbs to Improve the Success Rate of IVF-ET in Diminished Ovarian Reserve Patients","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-04-15","conditions":"Infertility, Female","enrollment":200},{"nctId":"NCT04819204","phase":"NA","title":"Testosterone and Neurovascular Control in Humans","status":"UNKNOWN","sponsor":"Western University, Canada","startDate":"2021-06","conditions":"Healthy","enrollment":20},{"nctId":"NCT03291821","phase":"NA","title":"DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2017-12-01","conditions":"Infertility, Female","enrollment":136},{"nctId":"NCT04418908","phase":"NA","title":"Estrogen, Diabetes, and Endothelial Function","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2010-11-24","conditions":"Type 1 Diabetes","enrollment":40},{"nctId":"NCT03373149","phase":"PHASE2","title":"Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response","status":"UNKNOWN","sponsor":"Riyadh Fertility and Reproductive Health center","startDate":"2017-11-29","conditions":"Infertility, Female","enrollment":228},{"nctId":"NCT04094467","phase":"PHASE4","title":"Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-12-07","conditions":"Polycystic Ovary Syndrome","enrollment":150},{"nctId":"NCT04308343","phase":"NA","title":"The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-03-30","conditions":"Ectopic Pregnancy","enrollment":120},{"nctId":"NCT04268927","phase":"PHASE2","title":"Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-04-01","conditions":"Infertility","enrollment":106},{"nctId":"NCT03181685","phase":"PHASE4","title":"Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles","status":"TERMINATED","sponsor":"Andros Day Surgery Clinic","startDate":"2016-12-20","conditions":"Infertility, In Vitro Fertilization","enrollment":60},{"nctId":"NCT03996434","phase":"PHASE4","title":"Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS","status":"COMPLETED","sponsor":"ClinAmygate","startDate":"2019-07-01","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":300},{"nctId":"NCT02821819","phase":"PHASE4","title":"Random-start Ovarian Stimulation in Egg-donors (ROSE)","status":"TERMINATED","sponsor":"Instituto Bernabeu","startDate":"2017-01-10","conditions":"Infertility","enrollment":15},{"nctId":"NCT02042196","phase":"EARLY_PHASE1","title":"Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2013-12","conditions":"Menopause, Aging","enrollment":100},{"nctId":"NCT04008966","phase":"PHASE4","title":"Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-07-20","conditions":"Assisted Reproduction","enrollment":160},{"nctId":"NCT03759301","phase":"PHASE4","title":"Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor Responders","status":"COMPLETED","sponsor":"ClinAmygate","startDate":"2018-12-20","conditions":"Infertility, Female","enrollment":156},{"nctId":"NCT03763786","phase":"PHASE4","title":"Frozen Embryo Transfer With GnRH-antagonist Trial","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2018-12-13","conditions":"Infertility","enrollment":300},{"nctId":"NCT02625532","phase":"NA","title":"Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial)","status":"UNKNOWN","sponsor":"Instituto Bernabeu","startDate":"2015-12","conditions":"Reproductive Techniques, Assisted","enrollment":60},{"nctId":"NCT01112358","phase":"PHASE2","title":"Lutropin Alfa in Women at Risk of Poor Response","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-12-07","conditions":"Ovarian Stimulation","enrollment":58},{"nctId":"NCT00449150","phase":"PHASE3","title":"Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)","status":"TERMINATED","sponsor":"AEterna Zentaris","startDate":"2007-03","conditions":"Benign Prostatic Hypertrophy","enrollment":667},{"nctId":"NCT03484611","phase":"NA","title":"Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2013-01","conditions":"Invitro Fertilizaion","enrollment":179},{"nctId":"NCT03477929","phase":"PHASE4","title":"Cetrorelix and Ganirelix Flexible Protocol for (IVF)","status":"UNKNOWN","sponsor":"Università degli Studi 'G. d'Annunzio' Chieti e Pescara","startDate":"2017-11-15","conditions":"Infertility/Sterility","enrollment":100},{"nctId":"NCT03457233","phase":"NA","title":"The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-01-03","conditions":"Invitro Fertilization","enrollment":185},{"nctId":"NCT03118830","phase":"PHASE4","title":"Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-04-21","conditions":"Invitro Fertilization","enrollment":204},{"nctId":"NCT01402336","phase":"PHASE3","title":"GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2011-06","conditions":"Infertility, Polycystic Ovary Syndrome","enrollment":43},{"nctId":"NCT03139474","phase":"PHASE2, PHASE3","title":"Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-06-01","conditions":"Infertility, Female","enrollment":120},{"nctId":"NCT01565265","phase":"NA","title":"Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2012-04","conditions":"Female Infertility Due to Nonimplantation of Ovum, Complications Associated With Artificial Fertilization","enrollment":5},{"nctId":"NCT02823080","phase":"PHASE2, PHASE3","title":"Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome","status":"UNKNOWN","sponsor":"Benha University","startDate":"2014-10","conditions":"Infertility","enrollment":48},{"nctId":"NCT01457703","phase":"NA","title":"Reproductive Hormonal Alterations in Obesity","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2010-06","conditions":"Obesity","enrollment":62},{"nctId":"NCT01590173","phase":"PHASE2, PHASE3","title":"Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2012-01","conditions":"Infertility","enrollment":86},{"nctId":"NCT01798862","phase":"PHASE2, PHASE3","title":"Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2013-03","conditions":"Repeated Implantation Failures","enrollment":100},{"nctId":"NCT02784457","phase":"PHASE2","title":"Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2014-06","conditions":"Assisted Reproduction","enrollment":84},{"nctId":"NCT01709942","phase":"PHASE3","title":"Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)","status":"COMPLETED","sponsor":"Centre for Endocrinology and Reproductive Medicine, Italy","startDate":"2012-11","conditions":"PCOS, OHSS, INFERTILITY","enrollment":80},{"nctId":"NCT01109888","phase":"PHASE1, PHASE2","title":"Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)","status":"WITHDRAWN","sponsor":"Wolfson Medical Center","startDate":"","conditions":"Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)","enrollment":""},{"nctId":"NCT02335736","phase":"PHASE2","title":"Antagonist Protocol in IVF","status":"UNKNOWN","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2015-01","conditions":"Infertility","enrollment":200},{"nctId":"NCT02333253","phase":"PHASE3","title":"Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-01","conditions":"Other Complications Associated With Artificial Fertilization","enrollment":60},{"nctId":"NCT02640976","phase":"EARLY_PHASE1","title":"Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program","status":"COMPLETED","sponsor":"Cairo University","startDate":"2013-06","conditions":"Infertility","enrollment":216},{"nctId":"NCT02461875","phase":"PHASE2","title":"Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome","status":"UNKNOWN","sponsor":"Aljazeera Hospital","startDate":"2013-05","conditions":"OHSS","enrollment":236},{"nctId":"NCT02442895","phase":"","title":"Biomarkers of Ovarian Reserve and Correlation With IVF Treatments","status":"COMPLETED","sponsor":"U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti","startDate":"2014-02","conditions":"Pregnancy, Ovarian","enrollment":236},{"nctId":"NCT02437032","phase":"PHASE4","title":"Gonadotropin Type in Ovarian Stimulation","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2009-04","conditions":"Infertility","enrollment":100},{"nctId":"NCT02392520","phase":"NA","title":"Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)","status":"UNKNOWN","sponsor":"Eugonia","startDate":"2015-05","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":40},{"nctId":"NCT02201914","phase":"PHASE4","title":"Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF","status":"UNKNOWN","sponsor":"Bioroma","startDate":"2014-01","conditions":"Poor Responders, IVF, Clomiphene Citrate","enrollment":250},{"nctId":"NCT01109654","phase":"","title":"An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-09","conditions":"Infertility","enrollment":2175},{"nctId":"NCT01669291","phase":"NA","title":"Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation","status":"COMPLETED","sponsor":"Main Line Fertility Center","startDate":"2012-07","conditions":"Fertility","enrollment":43},{"nctId":"NCT00298025","phase":"PHASE4","title":"A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2003-09","conditions":"Infertile Women Undergoing Assisted Reproductive Technology (ART)","enrollment":185},{"nctId":"NCT00866034","phase":"PHASE4","title":"Cetrotide Treatment Optimization","status":"TERMINATED","sponsor":"Bart CJM Fauser","startDate":"2009-02","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection","enrollment":617},{"nctId":"NCT01225835","phase":"PHASE4","title":"Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-10","conditions":"Infertility","enrollment":124},{"nctId":"NCT01079949","phase":"PHASE2","title":"A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2007-11","conditions":"Infertility, Ovulation Induction","enrollment":93},{"nctId":"NCT01185704","phase":"PHASE3","title":"Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-11","conditions":"Polycystic Ovarian Syndrome","enrollment":136},{"nctId":"NCT01948804","phase":"PHASE4","title":"The Comparison of Effect of Four Different Treatment Protocols on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization.","status":"UNKNOWN","sponsor":"Pınar Özcan Cenksoy","startDate":"2014-01","conditions":"Poor Responders Undergoing IVF","enrollment":100},{"nctId":"NCT01268761","phase":"PHASE3","title":"GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2012-04","conditions":"Ovarian Hyperstimulation Syndrome, Effects of Gonadotropin, Oocyte Maturation","enrollment":100},{"nctId":"NCT01668056","phase":"NA","title":"Synchronization of Ovarian Stimulation for in Vitro Fertilization With Follicular Wave Emergence","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2012-01","conditions":"Infertility","enrollment":30},{"nctId":"NCT01888744","phase":"PHASE4","title":"Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2010-09","conditions":"Reproductive Endocrinology, Fertility, Optimal Stimulation Protocol","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Cetrorelix pamoate, D-20762, AEZS-102"],"phase":"phase_3","status":"active","brandName":"Cetrorelix Pamoate","genericName":"Cetrorelix Pamoate","companyName":"AEterna Zentaris","companyId":"aeterna-zentaris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cetrorelix Pamoate is a gonadotropin-releasing hormone receptor antagonist used in controlled ovarian hyperstimulation for in vitro fertilization. It is indicated for conditions such as polycystic ovary syndrome, infertility, and diminished ovarian reserve.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}